Cerus (CERS) Tops Q1 EPS by 2c

Go back to Cerus (CERS) Tops Q1 EPS by 2c

Cerus Corporation Announces First Quarter 2022 Financial Results and Increases Full Year 2022 Product Revenue Guidance Range

May 5, 2022 4:00 PM EDT

Growth From All Geographic Regions with Results Driven by INTERCEPT Platelet Uptake in the U.S.

Total Revenue of $43.0 Million Grew 46% YoY in the First Quarter

Product Revenue of $37.4 Million Grew 60% YoY in the First Quarter

Increasing Full-Year 2022 Product Revenue Guidance Range from $157-164 Million to $160-165 Million

CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (Nasdaq: CERS) today announced financial results for the first quarter ended March 31, 2022.

Recent developments and highlights include:

First quarter 2022 total revenue of $43.0 million, reflecting a... More